Cargando…

The potential impact of COVID-19-related disruption on tuberculosis burden

Any benefit of social distancing on TB deaths is likely to be outweighed by health service disruption. As such, it is crucially important to maintain and strengthen TB-related health services during, and after, the COVID-19 pandemic. https://bit.ly/30aWZnp

Detalles Bibliográficos
Autores principales:	McQuaid, C. Finn, McCreesh, Nicky, Read, Jonathan M., Sumner, Tom, Houben, Rein M.G.J., White, Richard G., Harris, Rebecca C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278504/ https://www.ncbi.nlm.nih.gov/pubmed/32513784 http://dx.doi.org/10.1183/13993003.01718-2020

Ejemplares similares

Is neglect of self-clearance biassing TB vaccine impact estimates?
por: Scarponi, Danny, et al.
Publicado: (2023)

Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling
por: Knight, Gwenan M, et al.
Publicado: (2019)

Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China
por: Chen, Hongguang, et al.
Publicado: (2020)

Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan
por: Lee, Meng-Rui, et al.
Publicado: (2017)

An explanation for the low proportion of tuberculosis that results from transmission between household and known social contacts
por: McCreesh, Nicky, et al.
Publicado: (2018)

Estimating the contribution of transmission in primary healthcare clinics to community-wide TB disease incidence, and the impact of infection prevention and control interventions, in KwaZulu-Natal, South Africa
por: McCreesh, Nicky, et al.
Publicado: (2022)

The burden of progressive fibrotic interstitial lung disease across the UK
por: Simpson, Thomas, et al.
Publicado: (2021)

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2020)

Bedaquiline can act as core drug in a standardised treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis
por: Decroo, Tom, et al.
Publicado: (2022)

Tuberculosis prevention must integrate technological and basic care innovation
por: Mason, Paul H., et al.
Publicado: (2016)

Numbers needed to treat to prevent tuberculosis
por: Matteelli, Alberto, et al.
Publicado: (2015)

On tuberculosis and COVID-19 co-infection
por: Tadolini, Marina, et al.
Publicado: (2020)

Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis
por: Akkerman, Onno W., et al.
Publicado: (2018)

Screening for tuberculosis among high-risk groups attending London emergency departments: a prospective observational study
por: Gupta, Rishi K., et al.
Publicado: (2021)

Practices of therapeutic drug monitoring in tuberculosis: an international survey
por: Margineanu, Ioana, et al.
Publicado: (2022)

Global reporting on tuberculosis preventive treatment among contacts
por: Falzon, Dennis, et al.
Publicado: (2022)

Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV
por: Kerkhoff, Andrew D., et al.
Publicado: (2020)

Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union
por: van der Werf, Marieke J., et al.
Publicado: (2017)

Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2021)

QIAreach QuantiFERON-TB for the diagnosis of Mycobacterium tuberculosis infection
por: Saluzzo, Francesca, et al.
Publicado: (2022)

Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort
por: Bal, Christina, et al.
Publicado: (2022)

Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis
por: Tornheim, Jeffrey A., et al.
Publicado: (2022)

Variation in policy and practice of adolescent tuberculosis management in the WHO European Region
por: Blok, Nick, et al.
Publicado: (2016)

Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
por: Nimmo, Camus, et al.
Publicado: (2020)

The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region
por: Chiang, Chen-Yuan, et al.
Publicado: (2020)

A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis
por: Gupta, Nitesh, et al.
Publicado: (2020)

Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
por: Wells, Charles D., et al.
Publicado: (2015)

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
por: Tadolini, Marina, et al.
Publicado: (2016)

Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
por: Guglielmetti, Lorenzo, et al.
Publicado: (2022)

Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience
por: Sinkou, Heorhi, et al.
Publicado: (2017)

Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy
por: Magro, Paola, et al.
Publicado: (2020)

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
por: Tadolini, Marina, et al.
Publicado: (2020)

Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital
por: Stochino, Claudia, et al.
Publicado: (2020)

The high mental health burden of “Long COVID” and its association with on-going physical and respiratory symptoms in all adults discharged from hospital
por: Naidu, Sindhu B., et al.
Publicado: (2021)

Is neglect of self-clearance biasing TB vaccine impact estimates?
por: Scarponi, Danny, et al.
Publicado: (2023)

Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally
por: Masini, Tiziana, et al.
Publicado: (2022)

Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population
por: Taylor-Robinson, David C., et al.
Publicado: (2014)

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion
por: Sotgiu, Giovanni, et al.
Publicado: (2015)

A Bayesian Approach to Understanding Sex Differences in Tuberculosis Disease Burden
por: Horton, Katherine C, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o82dpv9edvub06ebgkpvrf8l43